Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Ann Hepatol ; 17(5): 864-870, 2018 08 24.
Artigo em Inglês | MEDLINE | ID: mdl-30145574

RESUMO

INTRODUCTION AND AIM: The detection of hepatitis B virus (HBV) depends on primary care center activity. The present study aims to investigate the impact of peer-to-peer sessions with hepatologists on hepatitis B screening efficacy in primary care centers. MATERIAL AND METHODS: Peer-to-peer one-hour sessions were scheduled to improve the screening program for HBV in Seville, Spain. The sessions were focused on who should be tested for HBV and how positive cases should be referred. Fourteen out of 26 health care centers were selected to participate in peer-to-peer sessions. The centers were classified according to how many sessions they held (no sessions, one session or more than one session). RESULTS: Over a five-year period, HBV screening was performed in 32 203 people. In Seville, the prevalence of HBsAg was 0.87% (283/32 203). The detection rates for new HBsAg-positive cases were 7.1, 16.9 and 21.3 cases/105 population/year in non-session, one-time session and more than one session centers, respectively (p < 0.05). The rate of patients who effectively visited centers as outpatients was significantly higher after peer-to-peer sessions-86/94 (91%) for one session and 81/89 (91%) for two session centers vs. 16/27 (67%) for non-session centers (p = 0.002). The only independent predictor of patient referral was peer-to-peer sessions (OR, 1.925 [95% CI, 1.002-3.699]; p < 0.05). CONCLUSIONS: Peer-to-peer sessions in primary care centers increased HBV detection and visitation rates.


Assuntos
Atitude do Pessoal de Saúde , Gastroenterologistas/psicologia , Conhecimentos, Atitudes e Prática em Saúde , Hepatite B Crônica/diagnóstico , Influência dos Pares , Médicos de Atenção Primária/psicologia , Atenção Primária à Saúde/métodos , Biomarcadores/sangue , Feminino , Antígenos de Superfície da Hepatite B/sangue , Vírus da Hepatite B/imunologia , Hepatite B Crônica/sangue , Hepatite B Crônica/virologia , Humanos , Comunicação Interdisciplinar , Masculino , Equipe de Assistência ao Paciente , Valor Preditivo dos Testes , Encaminhamento e Consulta , Espanha , Fatores de Tempo
2.
Rev Esp Enferm Dig ; 106(8): 544-7, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25544413

RESUMO

Low-phospholipid-associated cholelithiasis syndrome (LPAC) is associated with ABCB4 genetic mutation. ABCB4 encodes MDR3 protein, involved in biliary phosphatidylcholine excretion.Higher prevalence in women, biliary symptoms in young adults and ursodesoxycholic acid (UDCA) response are the main features. We report the case of a 48-year-old man with hepatitis C, genotype 1b, fibrosis F3, null responder to Peg-IFN-alpha-2b/ribavirin and nephritic colic. In 2011 he developed jaundice, pruritus and epigastric pain.He showed increased serum levels of AST, ALT, GGT, bilirubin and alpha-fetoprotein, and viral load (14,600,000 IU/mL). Pancreatic- CT, endoscopic ultrasonography and echo-Doppler showed noncirrhotic chronic liver disease. The episode resolved spontaneously and one year later he suffered a similar episode. UDCA was started with excellent response. An immunohistochemistry study and sequencing of ABCB4 did not find alteration. MLPA® technique detected heterozygous deletion of the full exon 4 confirming LPAC syndrome diagnosis.


Assuntos
Subfamília B de Transportador de Cassetes de Ligação de ATP/genética , Colestase Intra-Hepática/complicações , Colestase Intra-Hepática/genética , Hepatite C/complicações , Colestase Intra-Hepática/patologia , Éxons/genética , Deleção de Genes , Hepatite C/patologia , Humanos , Fígado/patologia , Masculino , Pessoa de Meia-Idade , Fosfolipídeos/deficiência , Síndrome
3.
Ann Hepatol ; 12(2): 341-2, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23538670
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA